Page 9 - ஐரோப்பிய நோய்த்தடுப்பு வாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Ещё двенадцать социальных объектов начнут строить в этом году в Москве
runews24.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from runews24.ru Daily Mail and Mail on Sunday newspapers.
Единую систему мониторинга окружающей среды предложили внедрить в России
newsprom.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsprom.ru Daily Mail and Mail on Sunday newspapers.
27 April 2021, 18:00 CEST
Follow our live event #WHOEuropeAnswers during European Immunization Week, where a panel of experts from WHO/Europe will answer your questions on COVID-19.
Tune in on Facebook, Twitter and YouTube.
During the event, post your questions in the comments and our panel will answer as many as possible. If you would like to ask questions in advance, let us know using the hashtag #WHOEuropeAnswers.
A real commitment from all stakeholders and policymakers is needed to support a catch-up immunisation campaign and overcome the difficulties routine vaccination programmes have experienced during the pandemic, according to a key vaccine stakeholder.
In an interview with EURACTIV, the new executive director of Vaccines Europe, Sibilia Quilici, said that while everyone is rightly focusing on the rollout of COVID-19 vaccination, there is also a concrete risk that other vaccination programmes might end up overlooked.
“Significant healthcare system resources are allocated to COVID-19 vaccination and little, if any, attention is given to routine immunisation to ensure continuity,” she said.
Routine national immunisation programmes are intended to protect the population against vaccine-preventable diseases such as measles, human papillomavirus-related diseases and cancers, influenza or pneumococcal infections, to name but a few. Such programmes are widely recognised as one of the wor
vimarsana © 2020. All Rights Reserved.